Overview of Dr. Philips
Dr. George Philips is an oncologist in Washington, DC and is affiliated with multiple hospitals in the area, including MedStar Washington Hospital Center and MedStar Georgetown University Hospital. He received his medical degree from Grant Medical College and has been in practice 31 years. Dr. Philips accepts several types of health insurance, listed below. He is one of 92 doctors at MedStar Georgetown University Hospital and one of 49 doctors at MedStar Washington Hospital Center who specialize in Oncology. He has more than 20 publications and over 500 citings.
Office
3800 Reservoir Rd Nw
Lombardi Cancer Center
Washington, DC 20007Fax+1 202-444-9429- Is this information wrong?
Education & Training
- University of ColoradoFellowship, Hematology and Medical Oncology, 1990 - 1995
- Grant Medical CollegeClass of 1986
Certifications & Licensure
- DC State Medical License 2010 - 2024
- MD State Medical License 2010 - 2013
- VT State Medical License 1999 - 2012
- CO State Medical License 1990 - 2001
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification ARIA Medical Oncology EMR, Varian Medical Systems, 2013
Clinical Trials
- 177Lu Radiolabeled Monoclonal Antibody HuJ591 (177Lu-J591) and Ketoconazole in Patients With Prostate Cancer Start of enrollment: 2009 Jun 01
- Cabozantinib-s-malate or Sunitinib Malate in Treating Patients With Previously Untreated Locally Advanced or Metastatic Kidney Cancer Start of enrollment: 2013 Jul 08
Publications & Presentations
PubMed
- 1 citationsAvelumab Plus Axitinib as First-Line Therapy for Advanced Renal Cell Carcinoma: Long-Term Results from the JAVELIN Renal 100 Phase Ib Trial.James Larkin, Mototsugu Oya, Marcella Martignoni, Fiona Thistlethwaite, Paul Nathan, Moshe C Ornstein, Thomas Powles, Kathryn E Beckermann, Arjun V Balar, David McDerm...> ;The Oncologist. 2023 Apr 6
- 6 citationsSTAG2 as a prognostic biomarker in low-grade non-muscle invasive bladder cancer.Ann Taber, Youngrok Park, Alana Lelo, Frederik Prip, Deborah L. Berry, Krysta Chaldekas, Jørgen Bjerggaard Jensen, George Philips, Jung-Sik Kim, Brent T. Harris, Lars ...> ;Urologic Oncology. 2021 Jul 1
- 83 citationsRandomized Double-Blind Phase II Study of Maintenance Pembrolizumab Versus Placebo After First-Line Chemotherapy in Patients With Metastatic Urothelial CancerMatthew D. Galsky, Amir Mortazavi, Matthew I. Milowsky, Saby George, Sumati Gupta, Mark D. Fleming, Long H. Dang, Daniel M. Geynisman, Radhika Walling, Robert S. Alter...> ;Journal of Clinical Oncology. 2020 Apr 9
- Join now to see all
Journal Articles
- STAG2 Is a Biomarker for Prediction of Recurrence and Progression in Papillary Non–Muscle-Invasive Bladder CancerCiaran Mannion, George Philips, Brent T Harris, Pritish Bhattacharyya, Jeffry Simko, Clinical Cancer Research
Professional Memberships
- Member
Hospital Affiliations
- MedStar Washington Hospital CenterWashington, District of Columbia
- MedStar Georgetown University HospitalWashington, District of Columbia
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
Anthem KeyCare PPO
BCBS Blue Card PPO
BCBS California CaliforniaCare HMO
BCBS California PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
First Health PPOGreat West PPO
HealthLink PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PHCS PPO - Kaiser
Multiplan PPO
Pacificare HMO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: